About admin

This author has not yet filled in any details.
So far admin has created 86 blog entries.

Amneal Pharmaceuticals LLC Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended Release Tablets, USP, 500 mg and 750 mg, Due to Detection of N-Nitrosodimethylamine (NDMA) Impurity

2020-06-22T19:25:00+00:00June 4th, 2020|

Amneal Pharmaceuticals LLC Bridgewater, New Jersey (Amneal), is voluntarily recalling all lots of Metformin Hydrochloride Extended Release Tablets, USP, 500 mg and 750 mg, within expiry to the Retail Level. Amneal was notified by the U.S. FDA that the Agency’s testing of seven lots of Metformin Hydrochloride Extended Release Tablets, USP, 500 mg and 750

Use the Correct Cycle and Compatible N95 Respirators When Decontaminating Respirators with STERRAD Sterilization Systems – Letter to Health Care Providers

2020-06-22T19:21:42+00:00May 30th, 2020|

The U.S. Food and Drug Administration (FDA) reminds reprocessing staff in health care facilities to use the correct decontamination cycle associated with certain models of the Advanced Sterilization Products (ASP) STERRAD Sterilization Systems and to only decontaminate compatible N95 or N95-equivalent respirators for reuse during the COVID-19 pandemic. ASP STERRAD Sterilization Systems use vaporized hydrogen

Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Certain Lots of NP Thyroid® (Thyroid Tablets, USP) Due to Super Potency

2020-05-27T13:16:03+00:00May 27th, 2020|

Acella Pharmaceuticals, LLC is voluntarily recalling a total of 13 lots of 30-mg, 60-mg and 90-mg NP Thyroid® (thyroid tablets, USP) to the consumer level. The products are being recalled because our testing has found these lots to be superpotent. The product may have up to 115.0% of the labeled amount of Liothyronine (T3). Risk

REMEMBER: NHSN Data Deadlines

2020-05-15T17:37:01+00:00May 15th, 2020|

NHSN is the nation’s most widely used healthcare-associated infection tracking system. NHSN provides facilities, states, regions, and the nation with data needed to identify problem areas, measure the progress of prevention efforts, and ultimately eliminate healthcare-associated infections. Contact the NHSN Helpdesk with any questions. 2020 NHSN Data Deadlines Q1 (Jan.-March 2020): June 30 Q2 (April-June 2020):

Patient Engagement and COVID-19

2020-05-15T17:09:34+00:00May 15th, 2020|

Social Distancing Challenge If you were wondering how to continue your patient engagement activities in light of the new guidelines with COVID-19 – Pella Dialysis is finding a way! Kyra Smith, MSW shared that they started a Social Distancing Challenge for the month of April, helping patients focus on the things patients (and staff) can

Grievance and Access to Care Audit Results

2020-05-15T14:38:07+00:00May 15th, 2020|

As part of the Network contract, the Network completes audits on the grievances and new access to care cases received during the first quarter (December-February) and third quarters of each contract year to identify trends and resource needs. Read further to find out about the results of the first quarter audits and plans to address

Patient Engagement Update and Tools

2020-05-15T14:42:10+00:00May 15th, 2020|

Per CMS Guidance, due to COVID-19 Pandemic Crisis all patient engagement and advocacy activities such as peer mentoring, attending support groups and participating in QAPI and Plan of Care meetings, should be done so virtually, over the telephone, online or thru another distant, non-person to person format to limit patient exposure risk. The Network encourages

June Topic of the Month: “My Life: Coping and Depression”

2020-05-18T17:19:36+00:00May 15th, 2020|

June Topic of the Month Patient Engagement Planning Sheet – “My Life: Coping and Depression” Due to the recent outbreak of COVID-19, the Network has changed the Patient Engagement Calendar to help address current needs surrounding infection control and coping. The Topic of the Month for May is “My Life: Prevention Saves Lives” and June

Important Information on the Use of Serological (Antibody) Tests for COVID-19 – Letter to Healthcare Providers

2020-04-27T14:26:04+00:00April 27th, 2020|

The U.S. Food and Drug Administration (FDA) recommends that healthcare providers continue to use serological tests intended to detect antibodies to SARS-CoV-2 to help identify people who may have been exposed to the SARS-CoV-2 virus or have recovered from the COVID-19 infection. Healthcare providers should also be aware of the limitations of these tests and

BSI April Update

2020-04-15T15:56:15+00:00April 15th, 2020|

QIA Resource Train your Brain to Relax Train your Brain to Relax is a tool that was created to help providers focus on the mental health of ESRD patients. This is a great time to regain that focus and to help provide stress relief to both patients and staff. The tool uses the technique of